Open AccessBlood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study
Author(s) -
Vivencio Barrios
Publication year - 2009
Publication title -
vascular health and risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.892
H-Index - 68
eISSN - 1178-2048
pISSN - 1176-6344
DOI - 10.2147/vhrm.s7003
Subject(s) - olmesartan , hydrochlorothiazide , medicine , blood pressure , urology , pharmacology , randomized controlled trial , diastole
Guidelines recommend blood pressure (BP) in hypertensive patients should be <140 systolic BP (SBP) and <90 diastolic BP (DBP) mmHg. This analysis assessed goal rate achievement in hypertensive patients receiving olmesartan-based treatment in the OLMEBEST study.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom